GSK still feeling effect of OTC supply issues

23 October 2014 - Deborah Wilkes

Archived

GlaxoSmithKline's Consumer Healthcare division reported worldwide sales down by 3% at constant exchange rates in the third quarter of 2014, as supply problems continued to affect several OTC brands. Including the impact of divestments made in 2013, the division's sales were down by 13%.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: